NATH BIOGENES (INDIA)
Back to Income Statement
|
NATH BIOGENES (INDIA) Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Net Sales | ₹365 Cr | ₹333 Cr | ₹301 Cr | ₹278 Cr | ₹138 Cr |
What is the latest Revenue of NATH BIOGENES (INDIA) ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹365 Cr |
| Mar2024 | ₹333 Cr |
| Mar2023 | ₹301 Cr |
| Mar2022 | ₹278 Cr |
| Mar2013 | ₹138 Cr |
How is Revenue of NATH BIOGENES (INDIA) Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹365 Cr | 9.71 | |
| Mar2024 | ₹333 Cr | 10.37 | |
| Mar2023 | ₹301 Cr | 8.26 | |
| Mar2022 | ₹278 Cr | 102.15 | |
| Mar2013 | ₹138 Cr | - | |
Compare Revenue of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹273.6 Cr | -4% | -4.3% | -9.5% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹11,316.7 Cr | -4.3% | -7.7% | -2.2% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹3,856.1 Cr | -2.8% | -19.9% | -27% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,809.5 Cr | -4.7% | -18.6% | -19.4% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹889.8 Cr | -5.6% | -7% | -37.8% | Stock Analytics | |
| INDO US BIOTECH | ₹226.3 Cr | -20.5% | -9.8% | -34.6% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | -4% |
-4.3% |
-9.5% |
| SENSEX | -4.1% |
-5.8% |
5.8% |
You may also like the below Video Courses